TrialCancer imaging : the official publication of the International Cancer Imaging Society2014

Metabolic response by FDG-PET to imatinib correlates with exon 11 KIT mutation and predicts outcome in patients with mucosal melanoma.

Katherine Zukotynski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.